【Renowned Expert Daily】 Professor Lan Shengmin: Consultations & Rounds – Precision Radiotherapy

【Renowned Expert Daily】 Professor Lan Shengmin: Consultations & Rounds – Precision Radiotherapy

On March 20, Professor Lan Shengmin, Chief Physician of the Radiotherapy Department at Shanxi Cancer Hospital, visited our hospital to conduct a series of clinical activities, including specialist consultations, rounds on complex cases, and guidance on radiotherapy techniques. Leveraging decades of profound expertise and extensive clinical experience in the field of tumor radiotherapy, Professor Lan significantly enhanced our hospital's radiotherapy specialty capabilities, bringing precise, standardized, and individualized high-quality radiotherapy and comprehensive diagnostic services to local and surrounding cancer patients, sparing them the hardship of traveling elsewhere for medical care.

Professor Lan Shengmin currently serves as Chief Physician in the Radiotherapy Department of Shanxi Cancer Hospital and concurrently as Vice Chairman of the Head and Neck Tumor Professional Committee of the Shanxi Branch of the China Anti-Cancer Association. He is a highly influential expert in the field of tumor radiotherapy within the province, possessing profound expertise in both clinical practice and academic research. With years of dedication to radiotherapy and comprehensive treatment of malignant tumors, he has accumulated extensive experience in managing complex and difficult tumor cases, earning widespread recognition in the field of tumor radiotherapy across Shanxi Province.

Professor Lan's areas of expertise are broad, focusing on the precise diagnosis, standardized treatment, and comprehensive prognostic analysis of various malignant tumors, including head and neck tumors, nervous system tumors, bone and soft tissue tumors, skin tumors, breast cancer, malignant lymphoma, lung cancer, and other common and challenging malignancies. He has particularly mature and well-developed diagnostic and treatment strategies for managing intracranial and cervical metastases arising from various malignant tumors. In clinical oncology, he integrates core techniques such as radiotherapy, hyperthermia, chemotherapy, and biotherapy, developing individualized treatment plans tailored to different disease conditions and patient constitutions. He holds unique insights and mature practices in the field of comprehensive treatment, excelling in combining multiple therapeutic modalities to improve tumor control rates and enhance patients' quality of life.

During his visit, Professor Lan Shengmin went to the radiotherapy ward and carefully reviewed the recovery status and treatment progress of hospitalized tumor patients. He patiently reassured patients, thoroughly answered various diagnostic and treatment questions raised by their families, and helped alleviate their anxiety. At the same time, based on the specific cases of the inpatients, he engaged in in-depth discussions with the medical and nursing teams from the radiotherapy department and related oncology specialties at our hospital. He provided detailed guidance on key aspects such as radiotherapy target delineation, treatment dose adjustment, optimization of comprehensive treatment plans, complication prevention and management, and prognostic follow-up. He shared cutting-edge treatment concepts and clinical practical experience, helping our medical and nursing teams further strengthen their foundational knowledge in radiotherapy and enhance their clinical diagnosis and treatment capabilities.

The visit and technical guidance provided by Professor Lan Shengmin represent an important initiative by our hospital to actively introduce high-quality provincial medical resources, address the shortfalls in the radiotherapy specialty, and enhance the development of key clinical specialties. As the only hospital in the world operating two heavy ion therapy systems simultaneously, Gansu Wuwei Cancer Hospital remains committed to the continuous development and innovation of tumor treatment technologies. Since the Wuwei Heavy Ion Center officially began clinical treatments in March 2020, it has successfully treated over 2,700 patients with remarkable clinical outcomes. The center covers a wide range of cancer types, including more than 50 indications such as lung cancer, pancreatic cancer, liver cancer, and glioblastoma. Patients come from diverse regions, including various provinces and municipalities across mainland China, as well as Hong Kong, Macau, and Taiwan. Additionally, the center has treated patients from countries such as Australia, Belgium, South Korea, Vietnam, and Malaysia.